1608
Aspirin-Exacerbated Respiratory Disease (AERD): Molecular Pathogenesis
Friday, February 20, 2015: 2:00 PM-5:00 PM
Convention Center, Level Three, Room 362
3.00 CME/ 3.40 CE
Primary Moderators:
Tanya M. Laidlaw , MD FAAAAI
Hae-Sim Park , MD FAAAAI

Learning Objectives

  1. Recognize the contribution of the innate immune system to AERD
  2. Recognize the novel mechanisms of mast cell and eosinophil activation during reactions to aspirin
  3. Recognize the role of epigenetic alterations in the eicosanoid pathways as potential causes of AERD
2:00 PM
Novel Connections Between Leukotriene Receptors and Mast Cells in AERD
Joshua A. Boyce, MD FAAAAI
2:25 PM
Aspirin as an Agonist for Eosinophil Activation
Larry Borish, MD FAAAAI
2:50 PM
ILC2 Cells as Effectors of Lipid Mediators
Taylor Doherty, MD FAAAAI
3:15 PM
Question & Answer
3:25 PM
Break
3:35 PM
Epigenetics of AERD
Scott T. Weiss , MD MS
4:00 PM
Activation of the Innate and Adaptive Immune Systems in Nasal Polyposis
Robert P. Schleimer, PhD FAAAAI
4:25 PM
The Switch to Abnormal Lipid Mediator Metabolism in AERD
Sven-Erik Dahlén, MD PhD
4:50 PM
Question & Answer
See more of: Course